We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Animalcare Group Plc | LSE:ANCR | London | Ordinary Share | GB0032350695 | ORD 20P |
| Price Change | % Change | Share Price | Shares Traded | Last Trade
|
|
|---|---|---|---|---|---|
| 2.00 | 0.90% | 223.00 | 16,269 | 10:07:42 |
| Bid Price | Offer Price | High Price | Low Price | Open Price | |
|---|---|---|---|---|---|
| 220.00 | 226.00 | 223.00 | 221.00 | 221.00 | |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Veterinary Service-livestock | 74.35M | 1.2M | 0.0174 | 128.16 | 152.46M |
| Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
|---|---|---|---|---|
| 17:08:03 | O | 2,000 | 223.00 | GBX |
| Date | Time | Source | Headline |
|---|---|---|---|
| 23/1/2025 | 15:52 | ALNC |  EARNINGS: PensionBee assets rise; Animalcare shares tick upwards |
| 23/1/2025 | 07:00 | UK RNS | Animalcare Group PLC 2024 Full Year Trading Update |
| 20/1/2025 | 07:00 | UK RNS | Animalcare Group PLC Exercise of Options and Total Voting Rights |
| 03/1/2025 | 10:12 | UK RNS | Animalcare Group PLC Completion of Randlab acquisition |
| 02/1/2025 | 10:11 | UK RNS | Animalcare Group PLC Notification of Total Voting Rights |
| 10/12/2024 | 07:00 | UK RNS | Animalcare Group PLC Appointment of Alternate Director |
| 06/12/2024 | 15:44 | UK RNS | Animalcare Group PLC Notification of Major Holding in the Group |
| 06/12/2024 | 15:11 | UK RNS | Animalcare Group PLC Notification of Major Holding in the Group |
| 06/12/2024 | 13:31 | UK RNS | Animalcare Group PLC PDMR Dealing |
| 06/12/2024 | 13:07 | UK RNS | Animalcare Group PLC Notification of Major Holding in the Group |
Animalcare (ANCR) Share Charts1 Year Animalcare Chart |
|
1 Month Animalcare Chart |
Intraday Animalcare Chart |
| Date | Time | Title | Posts |
|---|---|---|---|
| 12/3/2025 | 23:30 | Animalcare : contrarian value opportunity ? | 147 |
| 06/3/2019 | 20:37 | ANIMALCARE GROUP/Ritchey | 132 |
| Trade Time | Trade Price | Trade Size | Trade Value | Trade Type |
|---|
| Top Posts |
|---|
Posted at 15/3/2025 08:20 by Animalcare Daily Update Animalcare Group Plc is listed in the Veterinary Service-livestock sector of the London Stock Exchange with ticker ANCR. The last closing price for Animalcare was 221p.Animalcare currently has 68,984,915 shares in issue. The market capitalisation of Animalcare is £153,836,360. Animalcare has a price to earnings ratio (PE ratio) of 128.16. This morning ANCR shares opened at 221p |
Posted at 12/3/2025 23:30 by p1nkfish Orthros Medical is privately held, licensing to ANCR for VHH in canine and equine.Wonder what they are worth and revenue? Looks like a dinky little company with only 10 employees. Much better if ANCR could collaborate in the UK, imho. |
Posted at 12/3/2025 23:10 by p1nkfish ANCR have interests in Variable Heavy Chain Antibody that might lead somewhere useful.Having Winter and Mills involved in both companies is intriguing and EKF need a boost. They do have decent cash in bank and cashflow to fund a pivot. If they were to address VHH they would need to invest in new capabilities for them (immunoassays/antibo |
Posted at 12/3/2025 22:28 by p1nkfish EKF is being put through the ringer.ANCR CEO (Jenny Winter) is on the BoD. Both companies have Mills in common too. Wonder if Animalcare product developments involve collaboration with EKF going forward given a strategic fit, commonality in some Directors, and overlapping market interests. Dated 5th March 2025 - |
Posted at 06/3/2025 15:53 by simon gordon Would it be beneficial for ANCR to transition from AIM to the Main Market, where it could attract more natural buyers and access a deeper liquidity pool? Labour has been unfavorable toward AIM and has shown no initiative to revitalize London’s capital markets. |
Posted at 04/3/2025 20:19 by simon gordon Times - 4/3/25:London markets need a dose of optimism to keep them attractive No one is a bigger supporter of London’s capital markets than me. There are excellent people running finance companies and leading businesses in London. When our chairman, Andrew Brode, and I listed Learning Technologies Group (LTG) on the London Stock Exchange in 2013 we believed it was the best way to raise money to make deals. Last week, however, we both voted in favour of a takeover by the US private equity firm General Atlantic. LTG’s independent board came to the same conclusion. As a private company we will be better equipped to handle the challenges and opportunities that artificial intelligence presents with the backing of a private equity firm that understands how to help technology businesses to grow. So what does this say about the state of London’s markets? The Aim market gave LTG an exceptional platform in our first eight years as a listed company. We made 17 acquisitions to become the leading consolidator in the learning and talent development industry. This supported LTG’s growth from a hundred people and £10 million revenues in 2013 to more than five thousand people and nearly £500 million revenues today. The fact is, though, for the past three years the markets simply did not serve their purpose of raising money and valuing businesses fairly. The increasingly challenging macroeconomic backdrop has not been kind to the markets and LTG. Despite doubling profit in 2022 we lost a quarter of our value after a minor, technical balance sheet restatement. I reflected long and hard on London’s capital markets before deciding to leave. One of my conclusions is that investors disproportionately punish negative news but do not reward positive news. For instance, our share price reduced significantly because we had debt on our balance sheet as interest rates rose. By 2024 we eliminated our debt but our share price did not recover. This is not just a share price issue: it affects staff morale (many of our staff were in shareholder schemes), leadership team motivation and our ability to do deals. Ultimately this is why I left a market, Aim, that had served LTG extremely well for a long period. So what would it take for London’s markets to be attractive to entrepreneurs? I can think of three tangible fixes. First, we simply must have a stable political backdrop to breed confidence and encourage consumer spend. Second, government incentives are crucial. We need policies to encourage investors to put their money back into the stock market and boost liquidity. Third, investors and entrepreneurs need to see a continued commitment to reducing the regulatory burden on companies and markets. The new listing rules governing London’s capital markets are a good start but what about removing tax relief on risk-free cash Isas to encourage investment in AIM stocks? Structural fixes can provide a better foundation but will not change much without good old-fashioned chutzpah from business leaders and fund managers. Imagine the British adopting an American-style positive attitude (without losing our authenticity and identity) and then delivering on our stated ambitious goals. I have spent my entire business life making bold statements that I hold myself accountable to. Of course, one occasionally fails but if the environment is supportive and you learn from mistakes then everyone wins eventually. Positive thinking is infectious, empowering and enjoyable — and astonishingly easy to do, if you are so inclined. So for now LTG is pursuing value-creation with the help of a US private equity firm but I really care about London’s markets rediscovering their role as a vibrant global financial market. This is crucial for the UK economy and should mean a lot to us all. -Jonathan Satchell is chief executive of Learning Technologies Group |
Posted at 28/2/2025 11:26 by gopher The share price has slipped back recently and is much the same as 12 months ago despite solid progress and an earnings enhancing acquisition.I wonder whether the management are doing enough to promote the,company with PIs and institutions, There are plenty of good value companies around at the moment, concentrating on running the business not quite enough. |
Posted at 26/2/2025 11:41 by simon gordon City Am - 26/2/25:Pets at Home shares surge as watchdog set to go easy on vets The animal care retailer’s share price has been under pressure recently due to a Competition and Markets Authority probe into the veterinary sector. Investors are concerned the body will impose stricter regulations on the sector. However, Jeffries analysts have suggested that changes are “likely to be largely limited to improved transparency and regulation”, and reported increased confidence price controls will not be implemented. The CMA’s probe, which prompted over 56,000 responses from the public and vet industry, has been looking into the UK’s vet industry following concerns pet owners are not getting value for money. This included concerns that owners were being overcharged for medicine, as well as fear that consolidation by larger practices may reduce competition in the market. The investigation is key for Pets at Home, as its growth has been driven by revenue in its veterinary arm recently, with like-for-like growth of 19.9 per cent in the 12 weeks to January 2. Retail revenue fell 2.8 per cent in the same period. The most recent published papers on the probe, released by the CMA on February 6, noted concerns that customers had a limited choice of services and said that the price of vet services has risen faster than inflation. However, Jefferies analysts noted that profit margins in the sector are “largely unchanged,” adding that the CMA is unlikely to implement broad pricing control measures. “Our expert is optimistic about the outlook for the sector, believing that the trading headwinds are ‘transientR Animal care is a large and growing market – in 2022, consumers in the UK spent nearly £10bn on pet-related products, up nearly 100 per cent in a decade. Pets at Home has more than 400 surgeries across the UK. |
Posted at 24/1/2025 17:53 by gopher Thanks SimonThis is a very interesting acquisition and as I have said in the past the Company remains somewhat under the radar with its potential not baked into share price.Looking forward to Jenny Winters next update on investors meet platform, of course execution is everything. |
Posted at 23/1/2025 07:55 by simon gordon Panmure - 23/1/25:2025 -EPS: 14.1p 2026 -EPS: 16p Valuation remains attractive – While the share price reaction to the acquisition has been relatively muted, we think it has moved the valuation on from one based on the potential from acquisitions, to one based on reality. We remain of the view that Animalcare’s growth trajectory warrants a premium rating, and we value the shares at 330p based on 13x FY25E EV / EBITDA. This is supported by our DCF and sum of the parts valuations. The recent trading update was encouraging, with the numbers in line with expectations. In terms of risk, while acquisitions are never riskfree, we take comfort that the management team has learnt from the Ecuphar experience and structured the deal in such a way that Randlab will still benefit from the founder’s input, particularly around new product development. |
Posted at 04/1/2025 17:30 by p1nkfish Yes, will relook at 260 and 359.Yes, could fly, in no rush. Sensible management building for the long term. Was surprised the price they achieved for the tagging side of the business, was an excellent move. A bit overweight ANCR but see no reason to trim it, one to ride to see what happens. It also has something the likes of Zoetis need, decent growth potential with margins to be proud of along with increased geographic spread after recent acquisition. ZTS are OK geographically but a bit stale. Held them a few years back, Decent run 2018 for 3 years. They are also very active in Equine but ANCR would currently be noise to them as an acquisition. That may change in a few years, at a much higher price. |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
